Suppr超能文献

血红蛋白水平与血浆粪卟啉原 I 浓度的关系作为 OATP1B 表型分析的内源性探针。

Relationship of hemoglobin level and plasma coproporphyrin-I concentrations as an endogenous probe for phenotyping OATP1B.

机构信息

Department of Medication Use Analysis and Clinical Research, Meiji Pharmaceutical University, Kiyose, Japan.

Department of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.

出版信息

Clin Transl Sci. 2021 Jul;14(4):1403-1411. doi: 10.1111/cts.12996. Epub 2021 May 7.

Abstract

Plasma coproporphyrin-I (CP-I) concentration is used as a sensitive and selective endogenous probe for phenotyping organic anion transporting polypeptides 1B (OATP1B) activity in many studies. CP-I is produced in the process of heme synthesis, but the relationship between plasma CP-I concentrations and heme synthesis activity is unknown. In this study, we evaluated the relationship between plasma CP-I concentration and hemoglobin level as a biomarker of heme synthesis activity. The data of 391 subjects selected from the Japanese general population were analyzed. One hundred twenty-six participants had OATP1B115 allele, 11 of whom were homozygous (OATP1B115/15). Multiple regression analysis identified hemoglobin level as an independent variable associated with plasma CP-I concentration (p < 0.0001). A significant positive correlation was observed between hemoglobin level and plasma CP-I concentration in participants without OATP1B115 allele (n = 265; r  = 0.35, p < 0.0001) and with OATP1B1*15 allele (n = 126; r  =0.27, p = 0.0022). However, Kruskal-Wallis test showed no large difference in Kruskal-Wallis statistics between the distribution of plasma CP-I concentrations and that of ratio of plasma CP-I to hemoglobin among six OATP1B1 polymorphism groups. These findings suggest that the hemoglobin level seems to reflect biosynthesis of CP-I. However, correction by hemoglobin level is not required when using basal plasma CP-I concentration for phenotyping OATP1B activity.

摘要

血浆粪卟啉 I(CP-I)浓度被用作许多研究中鉴定有机阴离子转运多肽 1B(OATP1B)活性的敏感和选择性内源性探针。CP-I 是在血红素合成过程中产生的,但血浆 CP-I 浓度与血红素合成活性之间的关系尚不清楚。在这项研究中,我们评估了血浆 CP-I 浓度与血红蛋白水平作为血红素合成活性生物标志物之间的关系。分析了从日本普通人群中选择的 391 名受试者的数据。126 名参与者携带 OATP1B115 等位基因,其中 11 名是纯合子(OATP1B115/15)。多元回归分析确定血红蛋白水平是与血浆 CP-I 浓度相关的独立变量(p<0.0001)。在没有 OATP1B115 等位基因的参与者(n=265;r=0.35,p<0.0001)和携带 OATP1B1*15 等位基因的参与者(n=126;r=0.27,p=0.0022)中,观察到血红蛋白水平与血浆 CP-I 浓度之间存在显著正相关。然而,Kruskal-Wallis 检验显示,在六个 OATP1B1 多态性组中,血浆 CP-I 浓度的分布与血浆 CP-I 与血红蛋白比值的分布之间的 Kruskal-Wallis 统计值没有很大差异。这些发现表明,血红蛋白水平似乎反映了 CP-I 的生物合成。然而,在用基础血浆 CP-I 浓度进行 OATP1B 活性表型分析时,不需要通过血红蛋白水平进行校正。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b20/8301560/be7dac67dae0/CTS-14-1403-g003.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验